MA
RDY icon

MW Advisory’s Dr. Reddy's Laboratories RDY Stock Holding History

MW Advisory’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
+18,505
New +$250K 0.11% 114

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

MW Advisory's RDY Position: Q2 2026 in Review

MW Advisory opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 18,505 shares worth $268K. The stake represents 0.11% of the portfolio and ranks #114 among its holdings.

238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • MW Advisory held 18,505 shares of Dr. Reddy's Laboratories worth $268K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new MW Advisory position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.11% of MW Advisory's portfolio in Q2 2026, its #114 holding.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on MW Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.